Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

BRIGHT MINDS BIOSCIENCES INC.

BRIGHT MINDS BIOSCIENCES clinical programs — 1063 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

BRIGHT MINDS BIOSCIENCES projects

1,063 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,063 programs

Clinical programs

Page 19 of 23

  1. Adderall

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial

  2. Algorithm Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved small molecule completed

    1 trial

  3. Amantadine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  4. Antiretroviral therapy (ART)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  5. Athena strategy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved other active

    1 trial

  6. Atomoxetine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial

  7. BUP microdose induction

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    approved small molecule terminated

    1 trial

  8. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved other completed

    2 trials

  9. Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved other completed

    1 trial

  10. Behavioral: Buprenorphine/naloxone maintenance (Mtn)

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    approved other completed

    1 trial

  11. Bleomycin

    BRIGHT MINDS BIOSCIENCES INC.

    Keloid

    approved small molecule active

    1 trial

  12. Brand lamotrigine

    BRIGHT MINDS BIOSCIENCES INC.

    Epilepsy

    approved small molecule completed

    1 trial

  13. Brixadi (Injectable Buprenorphine)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  14. Buccal Buprenorphine 300 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    Analgesia

    approved small molecule active

    1 trial

  15. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    approved small molecule completed

    28 trials

  16. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  17. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    2 trials

  18. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

  19. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    approved small molecule completed

    2 trials

  20. Bupropion Extended Release Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Postpartum Smoking Relapse

    approved small molecule active

    1 trial

  21. Bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    2 trials

  22. Buspirone

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  23. Carbamazepine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    4 trials

  24. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  25. Cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    4 trials

  26. Cocaine-Related Disorders

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    2 trials

  27. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  28. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    approved small molecule completed

    1 trial

  29. Desipramine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  30. Double Blind Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule completed

    1 trial

  31. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial

  32. Drug: cimetidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    approved small molecule completed

    1 trial

  33. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  34. Egg based influenza vaccines

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    approved mab active

    1 trial

  35. Electronic Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule active

    1 trial

  36. Engerix-B 20 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved mab completed

    1 trial

  37. Erythromycin 4% topical gel formulation

    BRIGHT MINDS BIOSCIENCES INC.

    Acne Vulgaris

    approved small molecule active

    1 trial

  38. Extended-Release Buprenorphine (XRB)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  39. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  40. Fentanyl Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Function Loss

    approved small molecule active

    1 trial

  41. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  42. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Body Dysmorphic Disorder

    approved small molecule completed

    1 trial

  43. Fluoxetine + outpatient cognitive behavioral therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    approved small molecule completed

    1 trial

  44. HCV-001

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial

  45. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  46. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial

  47. IIV4 and PPV23

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza, Human

    approved mab completed

    1 trial

  48. IRB202101979 -A

    BRIGHT MINDS BIOSCIENCES INC.

    Pneumonia

    approved small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.